Sign inJoin waitlistJoin the waitlist

Alberto Chiappori

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

Medical Oncology
1992–1994
Internal Medicine
1989–1992
Doctor of Medicine
1985–1989

Research

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 3,824 citations
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine · 2018 · 2,311 citations
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results…
The Lancet Oncology · 2014 · 585 citations

Scott Antonia
36 papers
Eric Haura
33 papers
Jhanelle Gray
28 papers
Tawee Tanvetyanon
22 papers
GS
George Simon
20 papers
Ben Creelan
19 papers · 1 as a fellow
GB
Gerold Bepler
18 papers
Andreas Saltos
10 papers
DS
Daniel Sullivan
9 papers
Shirish Gadgeel
7 papers
Theresa Boyle
7 papers
Michael Shafique
6 papers

Clinical trials

Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
Principal investigator · Terminated · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2020–2023
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2019–2026
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
Principal investigator · Terminated · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2018–2022
Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Principal investigator · Completed · Phase 1
Palobiofarma SL
2015–2021